ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026
PURE-MRI: An international study assessing physician accuracy in delineating the prostate and urethra on prostate MRI.
Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Current state of the art of new prostate MRI technologies and potential future developments.BJR open · 2026Review
- Urethra contours on MRI: Multidisciplinary consensus educational atlas and reference standard for artificial intelligence benchmarking.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026Article
- PrecisionPro Fusion: Clinical validation of an automated, rigid, Prostate-Specific MRI-CT Fusion system for prostate radiotherapy planning.Technical innovations & patient support in radiation oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
purposePrecise delineation of genitourinary structures during prostate cancer (PCa) care is critical to optimize treatment delivery while minimizing toxicity and injury. The Prostate and UREthra on MRI (PURE-MRI) study is an international, prospective study to assess physicians' accuracy segmenting prostate and urethra on MRI.
methodsPhysicians who diagnose or treat PCa were invited to contour prostate and urethra on patient cases using standard T
results62 specialists from 11 countries created 114 prostate and 110 urethra contours. Prostate median (min, max) accuracy for physicians [vs. AI] was Dice score: 0.92 (0.62, 0.95) [vs. 0.95 (0.94, 0.96)], maximum deviation inside prostate: 3.4 mm (1.0, 12.4) [vs. 3.0 mm (3.0, 3.0)], maximum deviation beyond prostate: 5.3 mm (2.4, 17.3) [vs. 3.9 mm (3.1, 4.9)], mean deviation (per case) from the reference prostate: 1.6 mm (0.9, 3.9) [vs. 1.2 mm (1.1, 1.6)]. Urethra accuracy was Dice score: 0.33 (0.03, 0.69) [vs. 0.41 (0.35, 0.48)], coverage: 36 % (3 %, 96 %) [vs. 81 % (80 %, 91 %)], maximum (2D) deviation beyond urethra: 1.6 mm (1.0, 2.3) [vs. 1.7 mm (1.3, 2.1)].
conclusionPhysicians contour the prostate on MRI with overall Dice score >0.90, though typical cases still include at least one error >5 mm and sometimes >10 mm. Physician urethra contours were less accurate, with typical coverage of <40 % of the reference urethra (compared to >80 % for AI). Physician trainees performed similarly to experienced clinicians. AI tools give comparable accuracy to practicing physicians for prostate contours and achieve better coverage of the urethra.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.